BioSpace News Archive

Deals

Syneos Health to Acquire Synteract, Expand Its Global Expertise

Syneos Health announced on Wednesday that it has agreed to acquire Synteract, a full-service Contract Research Organization (CRO) focused on the biopharmaceutical industry.

October 29, 2020
·
3 min read
·
Krystle Vermes
Business

Fauci Predicts First COVID-19 Vaccine by Late December for High-Risk Americans

Fauci said the first COVID-19 vaccines could ship late December or early January.

October 29, 2020
·
2 min read
·
Kate Goodwin
Drug Development

Q32 Stays Busy with $60 Million Series B and First Dose in Phase I Trial

Q32 Bio rakes in $60 million Series B as they dose their first patient in IL-7R antibody trial.

October 29, 2020
·
2 min read
·
Kate Goodwin
Drug Development

AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ™ (upadacitinib) in Atopic Dermatitis

New RINVOQ analyses from the Measure Up 1 and 2 monotherapy studies show improvements in additional measures of skin clearance, itch and quality of life in adult and adolescent patients with moderate to severe atopic dermatitis[1]

October 29, 2020
·
18 min read
Business

Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) to Japan

MHLW and Takeda will import and distribute mRNA-1273 in Japan starting in the first half of 2021

October 29, 2020
·
5 min read
Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with Moderna and Government of Japan

Three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW) to bring Moderna’s COVID-19 vaccine candidate (mRNA-1273) to Japan

October 29, 2020
·
8 min read
Interim Management Statement Q3 2020 of Molecular Partners: Emergence of New Opportunities and Strong Platform Validation of DARPin® Therapeutics

Molecular Partners AG, a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced its interim management statement for the period ending September30, 2020.

October 29, 2020
·
13 min read
Deals

Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company

Acquisition of Vedere Bio includes lead preclinical intravitreally-injected AAV gene therapy programs focused on pan-genotypic vision restoration in patients with photoreceptor-based vision loss

October 29, 2020
·
4 min read
Deals

Takeda FY2020 H1 Results Demonstrate Portfolio Resilience; Confirms Full-Year Management Guidance & Raises Forecasts for Free Cash Flow, Reported OP & Reported EPS

FY2020 H1 results driven by growth of global brands (e.g. Entyvio +25.8% YOY, TAKHZYRO +45.5% YOY, NINLARO + 19.2% YOY); generated strong margins and cash flow

October 29, 2020
·
23 min read
Dr. Reddy’s partners with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India

Dr. Reddy’s Laboratories Ltd., announced its partnership with Biotechnology Industry Research Assistance Council, Department of Biotechnology, Government of India, for advisory support on clinical trials of Sputnik V vaccine in India.

October 29, 2020
·
5 min read